Glial Cell Derived Neurotrophic Factor Does not Provide Neuroprotection Against Alpha-Synuclein-Induced Toxicity in a Rat Model of Parkinson's Disease

被引：0
|
作者：
Decressac, M. [1 ]
Ulusoy, A. [1 ]
Kirik, D. [1 ]
Bjorklund, A. [1 ]
机构：
[1] Lund Univ, S-22100 Lund, Sweden
来源：
MOVEMENT DISORDERS | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S619 / S619
页数：1
相关论文
共 50 条
  • [21] Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease
    Yasuhara, Takao
    Shingo, Tetsuro
    Date, Isao
    ACTA MEDICA OKAYAMA, 2007, 61 (02) : 51 - 56
  • [22] Behavioral recovery in Parkinson's disease model by gene transfer of glial cell line-derived neurotrophic factor
    Zheng, JS
    Tang, LL
    Zhan, RY
    Zhou, YQ
    Chen, AF
    ANNALS OF NEUROLOGY, 2004, 56 : S11 - S11
  • [23] Alpha-synuclein-induced stress sensitivity renders the Parkinson's disease brain susceptible to neurodegeneration
    Bimpos, Modestos Nakos
    Karali, Katerina
    Antoniou, Christine
    Palermos, Dionysios
    Fouka, Maria
    Delis, Anastasios
    Tzieras, Iason
    Chrousos, George Panagiotis
    Koutmani, Yassemi
    Stefanis, Leonidas
    Polissidis, Alexia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [24] Growth differentiation factor 5 exerts neuroprotection in an a-synuclein rat model of Parkinson's disease
    Goulding, Susan R.
    Concannon, Ruth M.
    Morales-Prieto, Noelia
    Villalobos-Manriquez, Francisca
    Clarke, Gerard
    Collins, Louise M.
    Levesque, Martin
    Wyatt, Sean L.
    Sullivan, Aideen M.
    O'Keeffe, GerardW.
    BRAIN, 2021, 144 (02)
  • [25] Targeting the Receptor of Glial Cell Line-Derived Neurotrophic factor to treat Parkinson's Disease
    Sidorova, Y.
    Mahato, A.
    Saarma, M.
    MOVEMENT DISORDERS, 2020, 35 : S482 - S483
  • [26] In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease
    Kordower, JH
    ANNALS OF NEUROLOGY, 2003, 53 : S120 - S132
  • [27] Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease
    Wartiovaara, K
    Hytönen, M
    Vuori, M
    Paulin, L
    Rinne, J
    Sariola, H
    EXPERIMENTAL NEUROLOGY, 1998, 152 (02) : 307 - 309
  • [28] Unraveling the role of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease
    Kakoty, Violina
    Sarathlal, K. C.
    Kaur, Palwinder
    Wadhwa, Pankaj
    Vishwas, Sukriti
    Khan, Farhan R.
    Alhazmi, Abdulfattah Yahya M.
    Almasoudi, Hassan Hussain
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Paudel, Keshav Raj
    Kumar, Dileep
    Dua, Kamal
    Singh, Sachin Kumar
    NEUROLOGICAL SCIENCES, 2024, 45 (04) : 1409 - 1418
  • [29] GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease
    Decressac, Mickael
    Ulusoy, Ayse
    Mattsson, Bengt
    Georgievska, Biljana
    Romero-Ramos, Marina
    Kirik, Deniz
    Bjorklund, Anders
    BRAIN, 2011, 134 : 2302 - 2311
  • [30] Selective depletion of glial cell line-derived neurotrophic factor (GDNF) in Parkinson's disease
    Chauhan, NB
    Lee, JM
    Siegel, GJ
    NEUROLOGY, 1999, 52 (06) : A212 - A213
12345